[1]
Al-Rashida, M.; Iqbal, J. Therapeutic potentials of ecto‐nucleoside triphosphate diphosphohydrolase, ecto‐nucleotide pyrophosphatase/phosphodiesterase, ecto‐5′‐nucleotidase, and alkaline phosphatase inhibitors. Med. Res. Rev., 2014, 34(4), 703-743.
[2]
Robson, S.C.; Sévigny, J.; Zimmermann, H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal., 2006, 2(2), 409.
[3]
Vandenbeuch, A.; Anderson, C.B.; Parnes, J.; Enjyoji, K.; Robson, S.C.; Finger, T.E.; Kinnamon, S.C. Role of the ectonucleotidase NTPDase2 in taste bud function. Proc. Natl. Acad. Sci. , 2013, 110(36), 14789-14794.
[4]
Gillerman, I.; Lecka, J.; Simhaev, L.; Munkonda, M.N.; Fausther, M.; Martín-Satué, M.; Fischer, B. 2-Hexylthio-β, γ-CH2-ATP is an effective and selective NTPDase2 inhibitor. J. Med. Chem., 2014, 57(14), 5919-5934.
[5]
Lavoie, E.G.; Fausther, M.; Kauffenstein, G.; Kukulski, F.; Künzli, B.M.; Friess, H.; Sévigny, J. Identification of the ectonucleotidases expressed in mouse, rat, and human langerhans islets: Potential role of NTPDase3 in insulin secretion. Am. J. Physiol. Endocrinol. Metab., 2010, 299(4), E647-E656.
[6]
Baroja-Mazo, A.; Barbera-Cremades, M.; Pelegrin, P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta Biomembr., 2013, 1828(1), 79-93.
[7]
Leblanc, R.; Peyruchaud, O. New insights into the autotaxin/LPA axis in cancer development and metastasis. Exp. Cell Res., 2015, 333(2), 183-189.
[8]
Tsai, S.H.; Takeda, K. Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells. Semin. Immunopathol., 2016, 38(5), 571-579.
[9]
Millán, J.L.; Whyte, M.P. Alkaline phosphatase and hypophosphatasia. Calcif. Tissue Int., 2016, 98(4), 398-416.
[10]
Sharma, U.; Pal, D.; Prasad, R. Alkaline phosphatase: An overview. Indian J. Clin. Biochem., 2014, 29(3), 269-278.
[11]
Al-Rashida, M.; Qazi, S.U.; Batool, N.; Hameed, A.; Iqbal, J. Ectonucleotidase inhibitors: A patent review (2011-2016). Expert Opin. Ther. Pat., 2017, 27(12), 1291-1304.
[12]
Rahimova, R.; Fontanel, S.; Lionne, C.; Jordheim, L.P.; Peyrottes, S.; Chaloin, L. Identification of allosteric inhibitors of the ecto-5′-nucleotidase (CD73) targeting the dimer interface. PLOS Comput. Biol., 2018, 14(1)e1005943
[13]
Hassan, S.; Channar, P.A.; Larik, F.A.; Saeed, A.; Shah, H.S.; Lecka, J.; Sévigny, J.; Iqbal, J. Synthesis of new series of (E)-1-(2-(2-(4(dimethylamino) benzylidene) hydrazinyl)-4-methylthiazol-5-yl) ethanone derivatives as Ecto-5ʹ-Nucleotidase Inhibitors. Royal. Soc. Open Sci., 2018, 5180837
[14]
Macaev, F.; Boldescu, V.; Sucman, N.; Hassan, S.; Iqbal, J.; Neamtu, M.; Lecka, J.; Sévigny, J.; Prodius, D. Ectonucleotidase inhibitory and redox activity of imidazole-based organic salts and ionic liquids. ChemMedChem, 2018, 13, 2297-2304.
[15]
Dumontet, C.; Peyrottes, S.; Rabeson, C.; Cros-Perrial, E.; Géant, P.Y.; Chaloin, L.; Jordheim, L.P. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates. Eur. J. Med. Chem., 2018, 157, 1051-1055.
[16]
Rivera, R.P.; Hassan, S.; Ehlers, P.; Lecka, J.; Sévigny, J.; Rodríguez, E.T.; Iqbal, J.; Langer, P. Chemoselective synthesis and human ecto-5′-nucleotidase inhibitory activity of 2-trifluoromethyl-4,6-diarylquinolines. Chem. Select., 2018, 3, 8587-8592.
[17]
Kanwal; Khan, K.M.; Afzal, S.; Salar, U.; Lecka, J.; Sévigny, J.; Iqbal, J. Schiff bases of tryptamine as potent nucleoside triphosphate diphosphohydrolases (ntpdase) inhibitors: Synthesis and in vitro studies. Bioorg. Chem., 2019, 82, 253-266.
[18]
Kuhrt, D.; Ejaz, S.A.; Afzal, S.; Khan, S.U.; Lecka, J.; Sévigny, J.; Ehlers, P.; Spannenberg, A.; Iqbal, J.; Langer, P. Chemoselective synthesis and biological evaluation of arylated 2-(Trifluoromethyl) quinolines as nucleotide pyrophosphatase (NPPs) inhibitors. Eur. J. Med. Chem., 2017, 138, 816-829.
[19]
Ashraf, A.; Ejaz, S.A.; Rahman, S.U.; Siddiqui, W.A.; Arshad, M.N.; Lecka, J.; Sévigny, J.; Zayed, M.E.M.; Asiri, A.M.; Iqbal, J.; Hartinger, C.G.; Hanif, M. Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes. Eur. J. Med. Chem., 2018, 159, 282-291.
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Therapeutic Use of Plant Secondary Metabolites
Therapeutic Implications of Natural Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Article Metrics
39
8